Stay informed with the latest updates for the inheritable blood disorders community. Advocacy & Legislative Government Relations Update - June 2023Jul 6, 2023 Industry New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in ChildrenJul 3, 2023 Industry Hemophilia A Gene Therapy Product Receives U.S. FDA ApprovalJun 30, 2023 Medical Patient-Clinician Partnerships the Theme of ASCO Presidential AddressJun 26, 2023 Industry First Hemophilia B Patient Dosed with Gene Therapy ProductJun 20, 2023 NBDF & Community Shaping the Future: Search Begins for New NHF CEOJun 16, 2023 Peer-Reviewed Journal Summaries Inequities in Thrombosis and Hemostasis Lab Testing the Focus of…Jun 14, 2023 Peer-Reviewed Journal Summaries Gene Therapy as a Novel Approach to Achieving ITI in FVIII Inhibitors…Jun 7, 2023 NBDF & Community The King Years: A Legacy ContinuesJun 5, 2023 Advocacy & Legislative Government Relations Update - May 2023Jun 1, 2023 Industry Pfizer Highlights Phase 3 Trial Results of Marstacimab May 31, 2023 NBDF & Community Announcement from NHF CEO and PresidentMay 26, 2023 NBDF & Community It is Family: A Conversation with Saylor BehrensMay 22, 2023 NBDF & Community Get to Know the Nevada Chapter with Jacob MurdockMay 12, 2023 Medical Rare Disease Fellowship Program Now Accepting Applications! May 11, 2023 Pagination First page Previous page … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Last page